| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |